Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels

Domaine:

healthcare

Type de record:

paper
Créateur:
C. M. S. K,
Éditeur:
Spr
Hôte:
Abstract As countries decide on vaccination strategies and how to ease movement restrictions, estimating the proportion of the population previously infected with SARS-CoV-2 is important for predicting the future burden of COVID-19. This proportion is usually estimated from serosurvey data in two steps: first the proportion above a threshold antibody level is calculated, then the crude estimate is adjusted using external estimates of sensitivity and specificity. A drawback of this approach is that the PCR-confirmed cases used to estimate the sensitivity of the threshold may not be representative of cases in the wider population—e.g., they may be more recently infected and more severely symptomatic. Mixture modelling offers an alternative approach that does not require external data from PCR-confirmed cases. Here we illustrate the bias in the standard threshold-based approach by comparing both approaches using data from several Kenyan serosurveys. We show that the mixture model analysis produces estimates of previous infection that are often substantially higher than the standard threshold analysis.

Visit

doi.org

Licenses

https://creativecommons.org/licenses/by/4.0https://creativecommons.org/licenses/by/4.0

Similaires

Improving SARS-CoV-2 cumulative incidence estimation through mixture modelling of antibody levelsAssessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in Congolese individuals

Improving SARS-CoV-2 cumulative incidence estimation through mixture modelling of antibody levels

Abstract As countries decide on vaccination strategies and how to ease movement re

Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in Congolese individuals

Abstract Background Assessing immune responses after vaccination is part of the evaluatio